Evidence map›Paper›PMID 28828229›Full record

ArticlePeerJ2017

Correction: Screening of phospholipase A activity and its production by new actinomycete strains cultivated by solid-state fermentation.

Priscila Sutto-Ortiz, María de Los Angeles Camacho-Ruiz, Manuel R Kirchmayr, Meddy El Alaoui, Rosa María Camacho-Ruiz, Juan Carlos Mateos-Díaz, Alexandre Noiriel, Frédéric Carrière, Abdelkarim Abousalham, Jorge A Rodríguez

Abstract readPublished Erratum
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Priscila Sutto-OrtizBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.
María de Los Angeles Camacho-RuizBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.
Manuel R KirchmayrBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.
Meddy El AlaouiUniv Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), UMR 5246, Métabolisme, Enzymes et Mécanismes Moléculaires (MEM2), Villeurbanne Cedex, France.
Rosa María Camacho-RuizBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.
Juan Carlos Mateos-DíazBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.
Alexandre NoirielUniv Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), UMR 5246, Métabolisme, Enzymes et Mécanismes Moléculaires (MEM2), Villeurbanne Cedex, France.
Frédéric CarrièreCNRS, Aix Marseille Université, UMR 7282, Enzymologie Interfaciale et de Physiologie de la Lipolyse, Marseille, France.
Abdelkarim AbousalhamUniv Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires (ICBMS), UMR 5246, Métabolisme, Enzymes et Mécanismes Moléculaires (MEM2), Villeurbanne Cedex, France.
Jorge A RodríguezBiotecnología Industrial, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C., Zapopan, Jalisco, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.7717/peerj.3524.].

Identifiers

PMID28828229
PMCPMC5556489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.